Related Experiment Video

Updated: May 31, 2026

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice
07:25

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice

Published on: September 25, 2019

Treatment of hepatitis C-mediated glomerular disease

Ana Maria Sandri1, Usama Elewa, John J Poterucha

  • 1Division of Infectious Diseases, Hospital São Lucas da PUCRS, Porto Alegre, Brazil.

Nephron. Clinical Practice
|July 16, 2011
PubMed

Insights

Chronic hepatitis C virus (HCV) infection can cause chronic kidney disease (CKD). Optimal management strategies for HCV-mediated kidney disease are not well-defined, requiring further research into effective and safe treatments.

Area of Science:

  • Nephrology
  • Hepatology
  • Infectious Diseases

Background:

  • Chronic kidney disease (CKD) is a growing global health concern, exacerbated by hypertension, diabetes, and an aging population.
  • Chronic hepatitis C virus (HCV) infection frequently affects the kidneys, contributing to CKD and increasing patient morbidity and mortality.

Purpose of the Study:

  • To review current literature on managing kidney involvement in patients with HCV.
  • To discuss limitations of existing therapies and treatment-associated toxicities in CKD patients.
  • To identify future research directions for HCV-mediated kidney diseases.

Main Methods:

  • Literature review of recent studies on HCV and kidney disease.
  • Analysis of treatment options including antiviral drugs, immunosuppressants, plasmapheresis, and monoclonal antibodies.
  • Discussion of treatment efficacy, toxicity, and knowledge gaps.

Main Results:

  • HCV infection is a significant cause of CKD, impacting patient outcomes.
  • Current treatment strategies for HCV-mediated kidney disease lack large randomized controlled trials.
  • Available treatments carry potential toxicities, especially in patients with compromised renal function.

Conclusions:

  • Effective management of HCV-related kidney disease requires prompt recognition and tailored therapeutic approaches.
  • Further research is essential to define optimal treatment protocols and mitigate treatment-related risks in this vulnerable patient population.

More Related Videos

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis06:38

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis

Published on: September 12, 2019

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document any history...
Drug Elimination by Renal Route: Glomerular Filtration01:17

Drug Elimination by Renal Route: Glomerular Filtration

The kidney serves as the primary organ responsible for eliminating drugs and their metabolites from the body. This process, known as renal elimination, starts with glomerular filtration and results in urine formation. Each kidney houses millions of functional units called nephrons, where urine production takes place. A nephron has two main components: a renal corpuscle and a renal tubule. Drugs gain access to the kidney via the renal artery, which progressively branches off into afferent...
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy01:26

Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy

Continuous Renal Replacement Therapy (CRRT) is an essential intervention for patients experiencing severe kidney dysfunction. This therapy offers a continuous mechanism for removing fluids and toxins from the bloodstream, leveraging the patient’s blood pressure to facilitate filtration through a specialized filter. This method contrasts with intermittent dialysis, providing a gentler and more consistent removal of waste products and excess fluid, which is particularly beneficial in critically...